Metrikler
Yayın
56
Açık Erişim
31
BM Sürdürülebilir Kalkınma Amaçları
Makaleler
Tümü (48)
SCI-E, SSCI, AHCI (46)
SCI-E, SSCI, AHCI, ESCI (48)
ESCI (2)
Scopus (47)
TRDizin (1)
2024
20241. COST OF CHRONIC MYELOID LEUKAEMIA TREATMENT IN TÜRKIYE: RESULTS OF A DELPHI PANEL APPROACH
Saydam G., Eskazan E., GÜVENÇ B., Sonmez M., Toprak S., Tatar M., et al.
VALUE IN HEALTH
, sa.12, 2024 (SCI-Expanded, SSCI, Scopus)
2017
20172. The impact of pharmaceutical innovation on health outcomes and utilization in Turkey: A re-examination
Lichtenberg F. R., Tatar M., ÇALIŞKAN Z.
HEALTH POLICY AND TECHNOLOGY
, cilt.6, sa.2, ss.226-233, 2017 (SSCI, Scopus)
2016
20163. DIRECT COSTS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN TURKEY: A PANEL APPROACH
Tatar M., Tuna E., Senturk A., Sarioz F., Konya A.
VALUE IN HEALTH
, cilt.19, sa.7, 2016 (SCI-Expanded, SSCI, Scopus)
2016
20164. ADHERENCE TO GOLD CRITERIA STRATEGY IN TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS: COST IMPLICATIONS IN TURKEY
Tatar M., Tuna E., Senturk A., Sarioz F., Konya A.
VALUE IN HEALTH
, cilt.19, sa.7, 2016 (SCI-Expanded, SSCI, Scopus)
2016
20165. DIRECT COST OF HIV/AIDS IN TURKEY
Tatar M., Kockaya G., Ozelgun B., Elbir Z. T., Senturk A., Tuna E., et al.
VALUE IN HEALTH
, cilt.19, sa.7, 2016 (SCI-Expanded, SSCI, Scopus)
2016
20166. INDIRECT COST OF HIV/AIDS: RESULTS OF A SURVEY FROM A TURKISH RESEARCH CENTER
Tatar M., Kockaya G., Ozelgun B., Elbir Z. T., Senturk A., Tuna E., et al.
VALUE IN HEALTH
, cilt.19, sa.7, 2016 (SCI-Expanded, SSCI, Scopus)
2016
20167. INDIRECT COSTS OF STROKE IN TURKEY
Tatar M., Arsava E. M., Topcuoglu M. A., Caliskan Z., Karabulut E., Tuna E., et al.
VALUE IN HEALTH
, cilt.19, sa.7, 2016 (SCI-Expanded, SSCI, Scopus)
2016
20168. ORPHAN DRUG MARKET ANALYSIS IN TURKEY
Senturk A., Demir O., Tatar M., Ugurlu M., Sivaci C., Biter E., et al.
VALUE IN HEALTH
, cilt.19, sa.7, 2016 (SCI-Expanded, SSCI, Scopus)
2016
20169. INDIRECT COSTS OF EPILEPSY IN TURKEY: COST OF THE DISEASE IN TERMS OF WORK LOSS
Tatar M., Senturk A., Tuna E., Gurses C., Caliskan Z., Caglayan B., et al.
VALUE IN HEALTH
, cilt.19, sa.7, 2016 (SCI-Expanded, SSCI, Scopus)
2016
201610. COST OF TREATMENT OF HR+/HER2-POST MENOPAUSAL ADVANCED/METASTATIC BREAST CANCER PATIENTS IN TURKEY
Altundag K., Basaran G., Oksuzoglu B., Oven B., Ozguroglu M., Aydin D., et al.
VALUE IN HEALTH
, cilt.19, sa.3, 2016 (SCI-Expanded, SSCI, Scopus)
2016
201611. COMPARISON OF SUGAMMADEX AND NEOSTIGMINE USE IN TERMS OF COST SAVINGS IN HOSPITALS IN TURKISH HEALTHCARE SETTING
Tatar M., Tuna E., Senturk A., Alanoglu Z., Aypar U., Degirmenci S., et al.
VALUE IN HEALTH
, cilt.19, sa.3, 2016 (SCI-Expanded, SSCI, Scopus)
2015
201512. COST EFFECTIVENESS OF SODIUM OXYBATE IN TREATMENT OF CATAPLEXY IN PATIENTS WITH NARCOLEPY IN TURKEY
Tatar M., Tuna E., Caglayan B., Sarica N., Firidin A.
VALUE IN HEALTH
, cilt.18, sa.7, 2015 (SCI-Expanded, SSCI, Scopus)
2015
201513. GENERAL ASSESSMENT OF UNLICENSED MEDICINE USAGE IN TURKEY
Dogan E., Kockaya G., Tuna E., Yenilmez F. B., Vural I. M., Akbulat A., et al.
VALUE IN HEALTH
, cilt.18, sa.7, 2015 (SCI-Expanded, SSCI, Scopus)
2015
201514. DIRECT TREATMENT COSTS OF STROKE IN TURKEY
Tatar M., SENTURK A., TUNA E., KARABULUT E., ÇALIŞKAN Z., ARSAVA E. M., et al.
VALUE IN HEALTH
, cilt.18, sa.7, 2015 (SCI-Expanded, SSCI, Scopus)
2015
201515. LOCAL COST STUDY OF TREATMENT OF VENOUS THROMBOEMBOLISM IN TURKEY
Tatar M., Senturk A., Tuna E., Bilginer B., Ulus A. T., Buyuktuna N., et al.
VALUE IN HEALTH
, cilt.18, sa.7, 2015 (SCI-Expanded, SSCI, Scopus)
2015
201516. GENERAL ASSESSMENT OF UNLICENSED ANTINEOPLASTIC AND IMMUNOMODULATING MEDICINE USAGE SUBGROUPS IN TURKEY
Yenilmez F. B., Kockaya G., Dogan E., Tuna E., Vural I. M., Akbulat A., et al.
VALUE IN HEALTH
, cilt.18, sa.7, 2015 (SCI-Expanded, SSCI, Scopus)
2015
201517. GENERAL ASESSMENT OF UNLICENSED ANTINEOPLASTIC AND IMMUNOMODULATING MEDICINE USAGE IN TURKEY
Tuna E., Kockaya G., Yenilmez F. B., Dogan E., Vural I. M., Akbulat A., et al.
VALUE IN HEALTH
, cilt.18, sa.7, 2015 (SCI-Expanded, SSCI, Scopus)
2015
201518. COST SAVING STUDY OF FIVE GRASS POLLEN SLIT TABLET VERSUS SCIT'S & SYMPTOMATIC TREATMENT
Tatar M., Senturk A., Tuna E., Darrigol S., Girard L., Kayin I.
VALUE IN HEALTH
, cilt.18, sa.7, 2015 (SCI-Expanded, SSCI, Scopus)
2014
201419. DEVELOPMENT OF HTA IN TURKEY
Tuna E., Tatar M., Ergin G., Senturk A., Atikeler K.
VALUE IN HEALTH
, cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus)
2014
201420. IMPACT OF HEALTH POLICY CHANGES ON TRENDS OF PHARMACEUTICAL MARKET IN TURKEY
Yilmaz S. E., Kockaya G., Yenilmez F. B., Saylan M., Tatar M., Vural H. E., et al.
VALUE IN HEALTH
, cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus)
2014
201421. COST-EFFECTIVENESS OF OMALIZUMAB IN CHRONIC IDIOPATHIC URTICARIA REFRACTORY TO H1-ANTIHISTAMINES IN TURKEY
Tatar M., Sezen S., Senturk A., Balp M. M., Saylan M., Keskinaslan A.
VALUE IN HEALTH
, cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus)
2014
201422. COST-EFFECTIVENESS OF USE OF BARRICAID (R) IN LUMBAR DISCECTOMY SURGERY IN TURKEY
Tatar M., Senturk A., Dalgali Y.
VALUE IN HEALTH
, cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus)
2014
201423. IMPACT OF HEALTH POLICY CHANGES ON THE COST SALES OF 5 TOP SELLING ATC1 PHRAMACEUTICAL GROUPS IN TURKEY
Yenilmez F. B., Kockaya G., Saylan M., Yilmaz S. E., Tatar M., Vural H. E., et al.
VALUE IN HEALTH
, cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus)
2014
201424. COST-ANALYSIS OF CHRONIC IDIOPATHIC URTICARIA DISEASE
Tatar M., Senturk A., Ergin G., Tuna E., Mat C., Baskan B. E., et al.
VALUE IN HEALTH
, cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus)
2014
201425. VALUE OF LIFE AND COST OF PRE-MATURE DEATHS WITH THE PERSPECTIVE OF PRODUCTIVITY AS NET TAX REVENUE: A COMPARISON IN ARGENTINA, BRAZIL AND MEXICO
Atikeler K., Tuna E., Yenilmez F. B., Tatar M., Kockaya G.
VALUE IN HEALTH
, cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus)
2014
201426. VALUE OF LIFE AND COST OF PRE-MATURE DEATHS WITH THE PERSPECTIVE OF PRODUCTIVITY AS NET TAX REVENUE: A COMPARISON IN USA, CANADA, JAPAN AND AUSTRALIA
Yenilmez F. B., Tuna E., Atikeler K., Kockaya G., Tatar M.
VALUE IN HEALTH
, cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus)
2014
201427. VALUE OF LIFE AND COST OF PRE-MATURE DEATHS WITH THE PERSPECTIVE OF PRODUCTIVITY AS NET TAX REVENUE: A COMPARISON IN FRANCE, GERMANY, ITALY, SPAIN, UNITED KINGDOM
Tuna E., Yenilmez F. B., Atikeler K., Kockaya G., Tatar M.
VALUE IN HEALTH
, cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus)
2014
201428. IMPACT OF HEALTH POLICY CHANGES ON UNIT SALES OF 5 TOP SELLING ATC1 PHRAMACEUTICAL GROUPS IN TURKEY
Saylan M., Yilmaz S. E., Yenilmez F. B., Kockaya G., Tatar M., Vural H. E., et al.
VALUE IN HEALTH
, cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus)
2014
201429. IMPACT OF HEALTH POLICY CHANGES ON THE GROWTH LOCALLY MANUFACTURED AND IMPORTED PHARMACEUTICAL MARKETS OF TOP SELLING ATC1 PHRAMACEUTICAL GROUP (ALIMENTARY AND METABOLISM (A0) IN TURKEY
Kockaya G., Yenilmez F. B., Saylan M., Yilmaz S. E., Tatar M., Vural H. E., et al.
VALUE IN HEALTH
, cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus)
2014
201430. VALUE OF LIFE AND COST OF PRE-MATURE DEATHS WITH THE PERSPECTIVE OF PRODUCTIVITY AS NET TAX REVENUE FOR TURKEY
Kockaya G., Tuna E., Yenilmez F. B., Atikeler K., Tatar M.
VALUE IN HEALTH
, cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus)
2014
201431. IMPACT OF HEALTH POLICY CHANGES ON THE GROWTH LOCALLY MANUFACTURED AND IMPORTED PHARMACEUTICAL MARKETS IN TURKEY
Vural H. E., Kockaya G., Yenilmez F. B., Saylan M., Yilmaz S. E., Tatar M., et al.
VALUE IN HEALTH
, cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus)
2014
201432. AVAILABILITY OF RISK SHARING AGREEMENTS IN THE TURKISH PHARMACEUTICAL SECTOR
Tuna E., Tatar M., Ergin G., Senturk A., Atikeler K.
VALUE IN HEALTH
, cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus)
2014
201433. The effect of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey, 1999-2010
Lichtenberg F. R., Tatar M., ÇALIŞKAN Z.
HEALTH POLICY
, cilt.117, sa.3, ss.361-373, 2014 (SCI-Expanded, SSCI, Scopus)
2013
201334. Management of diabetes and diabetes policies in Turkey
Tatar M.
GLOBALIZATION AND HEALTH
, cilt.9, 2013 (SCI-Expanded, SSCI, Scopus)
2013
201335. Cost Analysis of Private Hemodialysis Centers in Turkey
TATAR M., Ergin G., Ecder T.
TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL
, cilt.22, sa.3, ss.270-282, 2013 (ESCI, Scopus, TRDizin)
2013
201336. Integration: the story from health economics and health policy perspective with examples from Turkey and Europe
TATAR M.
INTERNATIONAL JOURNAL OF INTEGRATED CARE
, cilt.13, 2013 (SCI-Expanded, SSCI, Scopus)
2012
201237. COST ANALYSIS OF DIALYSIS PRACTICE IN TURKEY
Tatar M., Oguzhan E. G., Kockaya G.
VALUE IN HEALTH
, cilt.15, sa.7, 2012 (SCI-Expanded, SSCI, Scopus)
2012
201238. COST-EFFECTIVENESS OF AGOMELATINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDERS IN TURKEY
Tatar M., Dilbaz N., Oral E. T., Tan M.
VALUE IN HEALTH
, cilt.15, sa.4, 2012 (SCI-Expanded, SSCI, Scopus)
2012
201239. A study on the identification of factors affecting the life quality of breast cancer patients
SOMUNOĞLU İKİNCİ S., TATAR M.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND HEALTHCARE MARKETING
, cilt.6, sa.4, ss.376-396, 2012 (ESCI, Scopus)
2010
201040. Predictors of Informal Health Payments: The Example from Turkey
Ozgen H., ŞAHİN B., Belli P., TATAR M., Berman P.
JOURNAL OF MEDICAL SYSTEMS
, cilt.34, sa.3, ss.387-396, 2010 (SCI-Expanded, Scopus)
2010
201041. COST EFFICACY OF USTEKINUMAB IN TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS IN TURKEY
Tatar M., Sarioz F.
VALUE IN HEALTH
, cilt.13, sa.3, 2010 (SCI-Expanded, SSCI, Scopus)
2010
201042. Colorectal cancer in Turkey: current situation and challenges for the future
TATAR M., Tatar F.
EUROPEAN JOURNAL OF HEALTH ECONOMICS
, cilt.10, ss.99-105, 2010 (SSCI, Scopus)
2009
200943. COST-EFFECTIVENESS OF SORAFENIB IN UNRESECTABLE AND/OR METASTATIC RENAL CELL CARCINOMA IN TURKEY
Tatar M., Akbulut H.
VALUE IN HEALTH
, cilt.12, sa.7, 2009 (SCI-Expanded, SSCI, Scopus)
2009
200944. THE USE OF SCREENING FOR EARLY DIAGNOSIS OF BREAST CANCER IN ANKARA
Somunoglu S., TATAR M.
SOCIAL BEHAVIOR AND PERSONALITY
, cilt.37, sa.8, ss.1101-1110, 2009 (SSCI, Scopus)
2007
200745. Informal payments in the health sector: A case study from Turkey
Tatar M., Ozgen H., Sahin B., Belli P., Berman P.
HEALTH AFFAIRS
, cilt.26, sa.4, ss.1029-1039, 2007 (SCI-Expanded, SSCI, Scopus)
2006
200646. Factors affecting use of resources for asthma patients
Sahin B., Tatar M.
JOURNAL OF MEDICAL SYSTEMS
, cilt.30, sa.5, ss.395-403, 2006 (SCI-Expanded, SSCI, Scopus)
2006
200647. Analysis of factors affecting patient satisfaction - Focus on asthma patients
Sahin B., Tatar M.
DISEASE MANAGEMENT & HEALTH OUTCOMES
, cilt.14, sa.3, ss.171-183, 2006 (SCI-Expanded, Scopus)
2006
200648. Analysis of Factors Affecting Patient Satisfaction A Case Study with Asthma Patients
ŞAHİN B., TATAR M.
Disease Management & Health Outcomes , cilt.14, sa.3, ss.171-183, 2006 (SCI-Expanded)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2015
20151. HOW PRICING AND REIMBURSEMENT POLICIES AFFECT THE BUDGET IMPACT OF THE TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS IN TURKEY
Tatar M., Tuna E., Oguzhan G., Senturk A., Sozeri B., Aktay Ayaz N., et al.
18th ISPOR Annual European Congress, Milan, İtalya, 7 - 11 Kasım 2015, cilt.18, (Özet Bildiri)
2015
20152. COST OF FAMILIAL MEDITERRANEAN FEVER (FMF) DISEASE IN TURKEY
Aksu K., Dokuyucu O., Ertenli A., Gul A., Karaaslan Y., KASAPÇOPUR Ö., et al.
18th ISPOR Annual European Congress, Milan, İtalya, 7 - 11 Kasım 2015, cilt.18, (Özet Bildiri)
2013
20133. Cost of Obesity for Turkey
Kockaya G., Tatar M., Ergin G., Atikeler K., Ozmen M., Gorgun M., et al.
18th World Congress of the International-Federation-for-the-Surgery-of-Obesity-and-Metabolic-Disorders (IFSO), İstanbul, Türkiye, 28 - 31 Ağustos 2013, cilt.23, ss.1143, (Özet Bildiri)
2013
20134. Cost of Obesity and Economic Value of Obesity Surgery for Turkey (CEVOS-T)
Tatar M.
18th World Congress of the International-Federation-for-the-Surgery-of-Obesity-and-Metabolic-Disorders (IFSO), İstanbul, Türkiye, 28 - 31 Ağustos 2013, cilt.23, ss.1079, (Özet Bildiri)
2013
20135. Economic Value of Obesity Surgery for Turkey
Kockaya G., Atikeler K., Ergin G., Tatar M., Ozmen M., Gorgun M., et al.
18th World Congress of the International-Federation-for-the-Surgery-of-Obesity-and-Metabolic-Disorders (IFSO), İstanbul, Türkiye, 28 - 31 Ağustos 2013, cilt.23, ss.1143, (Özet Bildiri)
2013
20136. Operational Cost of Obesity Surgery for Turkey
Kockaya G., Ergin G., Atikeler K., Tatar M., Ozmen M., Gorgun M., et al.
18th World Congress of the International-Federation-for-the-Surgery-of-Obesity-and-Metabolic-Disorders (IFSO), İstanbul, Türkiye, 28 - 31 Ağustos 2013, cilt.23, ss.1142-1143, (Özet Bildiri)
Kitaplar
2017
20171. Turkish Healthcare Reforms and Reasons for Failure
Tatar M., ERİGÜÇ G.
Health Policy and Economics, Tavakoli Manouche, Davies Huw T.O., Malek Mo, Editör, Routledge Revivals, 2017
2011
20112. Turkey Health Systems in Transition
TATAR M., MOLLAHALİLOĞLU S., ŞAHİN B., AYDIN S., MARESSO A., HERNANDEZ QUEVEDO C.
World Health Organization, Kopenhag, 2011